Figure 3.

MEG3 is of diagnostic value for risk factors. (A) MEG3 expression in patients with lymph node metastasis was significantly lower than that in patients without metastasis. (B) ROC curve of MEG3 in diagnosing lymph node metastasis of cervical cancer patients. (C) Expression of MEG3 in patients with stage III and IV was significantly lower than that of patients in stage I and II. (D) ROC curve of MEG3 in staging of cervical cancer patients. ***P<0.001. MEG3, maternally expressed 3; ROC, receiver operating characteristic.